Yibin Xu

7PUBLICATIONS
7CO-AUTHORS
Cancer diagnosisMolecular targetsChemotherapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 26, 2025
Copper-KRAS-COX2 Axis: A Therapeutic Vulnerability in Pancreatic Cancer.

Joyeeta Roy, Rima Mouawad, Armita Kyani

|Aug 17, 2023
First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer.

Yibin Xu, Ding Xue, Armita Kyani

|Feb 15, 2022
Multiparameter Optimization of Oxidative Phosphorylation Inhibitors for the Treatment of Pancreatic Cancer.

Ding Xue, Yibin Xu, Armita Kyani

|Jan 04, 2022
Discovery and Lead Optimization of Benzene-1,4-disulfonamides as Oxidative Phosphorylation Inhibitors.

Ding Xue, Yibin Xu, Armita Kyani

|Oct 26, 2020
Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?

Yibin Xu, Ding Xue, Armand Bankhead

Pageof 2